Form 8-K - Current report:
SEC Accession No. 0001601485-25-000022
Filing Date
2025-03-24
Accepted
2025-03-24 07:03:16
Documents
24
Period of Report
2025-03-21
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K angn-20250321.htm   iXBRL 8-K 30554
2 EX-10.1 confidential-elicioemplo.htm EX-10.1 19810
3 EX-99.1 cfo_announcementxpr.htm EX-99.1 12184
7 cfo_announcementxpr001.jpg GRAPHIC 249928
8 cfo_announcementxpr002.jpg GRAPHIC 273881
9 cfo_announcementxpr003.jpg GRAPHIC 184337
10 confidential-elicioemplo001.jpg GRAPHIC 221588
11 confidential-elicioemplo002.jpg GRAPHIC 249604
12 confidential-elicioemplo003.jpg GRAPHIC 260753
13 confidential-elicioemplo004.jpg GRAPHIC 222799
14 confidential-elicioemplo005.jpg GRAPHIC 201399
15 confidential-elicioemplo006.jpg GRAPHIC 134516
  Complete submission text file 0001601485-25-000022.txt   2962085

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT angn-20250321.xsd EX-101.SCH 1870
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT angn-20250321_lab.xml EX-101.LAB 22786
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT angn-20250321_pre.xml EX-101.PRE 13130
27 EXTRACTED XBRL INSTANCE DOCUMENT angn-20250321_htm.xml XML 2907
Mailing Address 451 D STREET, 5TH FLOOR BOSTON MA 02210
Business Address 451 D STREET, 5TH FLOOR BOSTON MA 02210 (857) 209-0050
Elicio Therapeutics, Inc. (Filer) CIK: 0001601485 (see all company filings)

EIN.: 113430072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39990 | Film No.: 25762198
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)